ABSTRACT A total of 450 one-day-old Arbor Acres male chickens were used to investigate the effects of zinc oxide-montmorillonite hybrid (ZnO-MMT) on growth performance, intestinal structure, and function. The birds were allotted to 5 dietary treatments for 21 d, each of which was replicated 6 times with 15 chicks per replicate. The dietary treatments were 1) corn-soybean meal diet (basal, containing 42.35 mg of Zn/kg); 2) basal diet + 600 mg of MMT/kg (equivalent to the MMT in the ZnO-MMT treatment); 3) basal diet + 60 mg of Zn/kg as ZnO; 4) basal diet + 60 mg of Zn/kg as ZnO-MMT; and 5) basal diet + 60 mg of Zn/kg as ZnSO 4 ·7H 2 O. The results showed that chicks fed ZnO-MMT had higher (P < 0.05) ADG and feed intake than those fed the basal diet, MMT, or ZnO. Compared with the control, MMT, ZnO, or ZnSO 4 , supplementation with ZnO-MMT decreased (P < 0.05) viable counts of Clostridium in small intestinal and cecal contents, increased (P < 0.05) colonic transepithelial electrical resistance (TER) values, and reduced (P < 0.05) colonic probe mannitol permeability as well as ileal or colonic inulin permeability. Compared with the control, supplemental ZnO-MMT increased (P < 0.05) villus height, the ratio of villus height to crypt depth at the small intestinal mucosa, the trypsin activity in the pancreas, and the digestive enzyme activities in small intestinal contents. Compared with the control, supplementation with ZnO increased (P < 0.05) the villus height and the villus height to crypt depth ratio at the duodenum. Supplementation with ZnSO 4 increased the trypsin activity in pancreas and small intestinal contents. However, supplemental MMT, ZnO, or ZnSO 4 did not affect (P > 0.05) growth performance, ileal and colonic barrier function, and intestinal microflora. The results indicated that supplementing 60 mg of Zn/kg as ZnO-MMT in broiler chickens improved growth performance, intestinal microflora, intestinal morphology, and barrier function as well as the digestive enzyme activities.
INTRODUCTION
The role of zinc in the anti-inflammatory response and resistance to infection is well known (Lang et al., 2007) . In particular, ZnO appears to have a strong protective effect in resisting intestinal diseases (Roselli et al., 2003) . Studies evaluating the healing of skin wounds in pigs found that ZnO is more effective than ZnSO 4 in promoting healing; topical ZnO enhances reepithelialization, whereas ZnSO 4 is ineffective (Agren et al., 1991) .The amounts of ZnO used in these studies greatly exceeded physiological requirements (Roselli et al., 2003) . Pharmacological use of zinc oxide (2,000 to 3,000 mg of ZnO/kg) is widely accepted as the means of controlling postweaning diarrhea (Poulsen, 1995; Hu et al., 2012a,b) . However, the strategy is criticized because high levels of zinc are excreted into the environment. Preventing the absorption or chemical change of ZnO in the stomach and slow release of ZnO further down in the intestinal tract may be a good means to improve its effectiveness (Hu et al., 2012a,b) .
Montmorillonite (MMT), an aluminosilicate clay, is composed of silica tetrahedral sheets layered between an alumina octahedral sheets. The imperfection of the crystal lattice and the isomorphous substitution induce a net negative charge that leads to the adsorption of alkaline earth metal ions in the interlayer space. Such imperfection is responsible for the exchange reactions with drugs (Slamova et al., 2011) . Montmorillonite is a common ingredient as both the excipient and active substance in pharmaceutical products (Carretero and Pozo, 2009) . Animal feed containing MMT has been shown to promote growth performance and reduce the detrimental effects of mycotoxin-contaminated diets (Tauqir and Nawaz, 2001; Slamova et al., 2011) . In recent years, MMT is used as carrier for modulating drug delivery because of its high surface area, strong adsorptive capacity, high cation exchange capacity, and standout adhesive ability. Montmorillonite intercalated by drug molecules exhibit novel physical and chemical properties. Many researchers have studied the drug-MMT interactions and found that drug-MMT hybrid can target drug release, improve drug dissolution, increase drug stability, and modify drug delivery patterns (Kollár et al., 2003; Zheng et al., 2007; Park et al., 2008; Joshi et al., 2009; Meng et al., 2009) .
Zinc oxide-montmorillonite hybrid (ZnO-MMT) with novel physicochemical properties has recently been synthesized by a sol-gel intercalation reaction (Hu et al., 2012a,b) . Maintenance or enhancement of gut health is essential for the poultry welfare and productivity. Any gut damage will lead to poor gut health, which will, in turn, affect nutrient utilization efficiency (Choct, 2009) . Whether ZnO-MMT is able to improve the intestinal structure and function of broilers remains to be elucidated. Therefore, an experiment was carried out to investigate the effects of ZnO-MMT on growth performance, intestinal microflora, the digestive enzyme activities of pancreas and small intestinal contents, and intestinal morphology of broiler chickens. Moreover, ex vivo Ussing chamber studies were conducted to measure ileal and colonic barrier function in terms of transepithelial electrical resistance (TER) and paracellular flux of large inulin and small mannitol molecules.
MATERIALS AND METHODS

Materials
Montmorillonite used in the present work was a hydrothermal product of volcanic sedimentary rocks from the Inner Mongolia Autonomous Region, China. The raw material was dried at 80°C for 24 h, milled to 300-mesh, and then dispersed in water to form a 10% suspension. Particles were separated out by sedimentation, and the suspension was centrifuged at 10,000 × g for 15 min at room temperature to obtain refined MMT. The refined MMT was dried at 80°C followed by another milling to 300-mesh. The content of the purified MMT is 99%.
Zinc oxide-montmorillonite hybrid was synthesized using a sol-gel intercalation (Khaorapapong et al., 2011; Hu et al., 2012a,b) . The aqueous solution of zinc chloride was mixed with sodium hydroxide solution at the molar ratio of Zn 2+ :OH − of 1:10 and vigorously stirred at 70°C for 24 h. The aqueous mixture of zinc chloride and sodium hydroxide solutions was added into the colloidal suspension of exfoliated MMT with continuous stirring at 70°C, and the mixture was allowed to react for 24 h. The resulting solids were separated by centrifugation at a speed of 10,000 × g for about 15 min at room temperature, washed 3 times with distilled water, and dried at 50°C for 3 d. The Zn content in ZnO-MMT was found to be 10% on the basis of atomic absorption spectral analysis (AOAC International, 2000) .
Birds and Diets
All procedures were approved by the Institutional Animal Care and Use Committee of Zhejiang University. A total of 450 one-day-old Arbor Acres male broilers were used in the 21-d feeding experiment. The birds were randomly allotted to 5 dietary treatments, each of which was replicated 6 times with 15 chicks per replicate. The dietary treatments were 1) basal corn-soybean meal diet containing no exogenous Zn (containing 42.35 mg of Zn/kg); 2) basal diet + 600 mg of MMT/ kg (equivalent to the MMT in the ZnO-MMT treatment); 3) basal diet + 60 mg of Zn/kg as analytical grade (AG) ZnO; 4) basal diet + 60 mg of Zn/kg as ZnO-MMT; and 5) basal diet + 60 mg of Zn/kg as AG ZnSO 4 ·7H 2 O. Diets were formulated to meet or exceed requirements suggested by the NRC (1994; Table 1 ). The CP, lysine, methionine, calcium, phosphorus, and zinc of diets were determined by methods of AOAC International (2000) . The chicks were raised in wooden cages (120 × 110 × 50 cm, length × width × height), equipped with nipple waterers and tube feeders. All chicks were given ad libitum access to feed and water for 21 d. Temperature and lighting was maintained according to commercial conditions. Average daily gain, ADFI, and G:F were calculated. At d 21 of the feeding trial, 18 chicks per treatment (3 per cage) were slaughtered by severing the jugular veins. The birds were then immediately eviscerated for collection of gastrointestinal tract digesta, pancreatic tissue, and intestinal samples. Samples of the contents from the small intestine (from the distal end of the duodenum to the ileo-cecal junction) and cecum were immediately collected into glass containers under CO 2 , sealed, and put on ice until they were transported to the laboratory for enumeration of microbial populations. Pancreatic tissue and small intestinal content samples were collected and stored at −80°C until digestive enzyme analysis. Segments were removed from the duodenum, jejunum, and ileum as follows: 1) intestine from the gizzard to pancreatic and bile ducts was referred to as the duodenum, the middle section of which was taken for microscopy; 2) midway between the point of entry of the bile ducts and Meckel's diverticulum (jejunum), and 3) 10 cm proximal to the ileocecal junction (ileum).
Intestinal Microbial Populations
The total viable counts of Clostridium and Escherichia coli in the small intestine and cecum of chickens were analyzed by the method of Hu et al. (2012a) . Bacteria were enumerated on Sulphite-Polymyxin Milk Agar (Mevissen-Verhage et al., 1987; Clostridium) , and MacConkey's No. 2 (Oxoid; Escherichia coli). The bacteria were characterized to genus level on the basis of colonial appearance, gram reaction, spore production, cell morphology, and fermentation end product formation.
Ileal and Colonic Barrier Function
Segments of ileum and colon were immediately harvested after the chicks were killed and prepared for Ussing chamber studies to measure the TER and paracellular fluxes. Manipulation and experimental procedures were performed in accordance with Awad et al. (2004) . Segments of ileum and colon were stripped from the seromuscular layer in oxygenated (95% O 2 /5% CO 2 ) Ringer's solution (mmol/L: CaCl 2 , 1.2; MgCl 2 , 1.2; Na 2 HPO 4 , 2.4; NaH 2 PO 4 , 0.4; NaHCO 3 , 25; KCl, 5; NaCl, 115; pH 7.4). Tissues were then mounted in the EasyMount Ussing chamber system with a multichannel voltage-current clamp (model VCC MC6, Physiologic Instruments, San Diego, CA). The clamps were connected to Acquire and Analyze software (Physiologic Instruments) for automatic data collection. Tissues were bathed on the serosal and mucosal sides with 5 mL of Ringer's solution. The serosal bathing solution contained 10 mmol of glucose/L, which was osmotically balanced on the mucosal side with 10 mmol of mannitol/L. Bathing solutions were oxygenated (95% O 2 /5% CO 2 ) and circulated in water-jacketed reservoirs maintained at 38°C. Mucosal-to-serosal fluxes of 3 H-labeled mannitol and 14 C-inulin were performed at the same time. After a 15-min period on Ussing chambers, 0.2 mCi/L of 3 H-labeled mannitol (180 Da) and 14 C-inulin (5000 Da; Sigma Chemical) were added to the mucosal side of Ussing chamber-mounted tissues, as previously described by Smith et al. (2010) and Peace et al. (2011) .
Intestinal Morphometry
The segments from the duodenum, jejunum, and ileum were flushed with physiological saline and fixed in 10% formalin. Three cross-sections for each intestinal sample were stained with hematoxylin and eosin using standard paraffin embedding procedures (Xia et al., 2004; Hu et al., 2012a) . A total of 10 intact, well-oriented crypt-villus units were selected in triplicate for each intestinal cross-section. Villus height was measured from the tip of the villi to the villus crypt junction, and crypt depth was defined as the depth of the invagination between adjacent villi. Morphological indices were determined using image processing and analysis system (Version 1, Leica Imaging Systems Ltd., Cambridge, UK).
Digestive Enzyme Activities in Pancreatic Tissue and Small Intestinal Contents
The following sampling procedures were conducted according to the method described by Hu et al. (2012b) . The pancreas and small intestinal digesta samples was thawed and homogenized in 4 volumes of ice-cold 0.9% NaCl. The homogenate was centrifuged (13,800 × g for 20 min at 4°C), and the supernatant were analyzed for digestive enzymes activities. Amylase (a-1, 4-glucan 4-glucanohydrolase, EC 3.2.1.1) activity was determined using the method of Somogyi (1960) . Amylase activity unit was defined as the amount of amylase that will cause formation of reducing power equivalent to 1 mg of glucose in 1 h. The substrate used in the analysis was cornstarch. Lipase (triacylglycerol lipase, EC 3.1.1.3.) activity was assayed using the method described by Tietz and Fiereck (1966) . Lipase activity unit was equal to the volume (mL) of 0.05 M NaOH required to neutralize the fatty acid liberated during 2 h incubation. Olive oil was used as the substrate in this assay. Trypsinogen and chymotrypsinogen in pancreatic homogenates were activated as previously described (Hedemann et al., 2006) , whereas trypsin (EC 3.4.21.4) and chymotrypsin (EC 3.4.21.1) in digesta were determined without activation. The substrate used for trypsin and chymotrypsin determination was Nα-Benzoyl-dl-arginine 4-nitroanilide hydrochloride (B4875, Sigma, St. Louis, MO) and N-Succinyl-AlaAla-Pro-Phe p-nitroanilide (S7388, Sigma), respectively. One unit of trypsin or chymotrypsin activity was defined as the hydrolysis of 1 μmol of substrate per minute. The intestinal digesta protein concentrations were determined by the method of Lowry et al. (1951) . Ovine serum albumin was used as a standard. Digestive enzymes activities in pancreas and small intestinal contents were expressed as unit per milligram of intestinal digesta protein and unit per gram of wet pancreatic tissue, respectively.
Statistical Analysis
One-way ANOVA was performed using the GLM procedure (SAS, 1989) . Differences among means were tested using Duncan's multiple range tests. A significance level of 0.05 was used.
RESULTS
Growth Performance
Growth performance of chicks is presented in Table  2 . Chicks fed 60 mg of Zn/kg as ZnO-MMT had higher (P < 0.05) ADG and ADFI than those fed the basal diet, MMT, or 60 mg of Zn/kg as ZnO. Chicks fed 60 mg of Zn/kg as ZnSO 4 had greater (P = 0.07) ADG than the control, although the tendency was not significant. Supplementation with MMT or ZnO had no (P > 0.05) effect on growth performance. The G:F was not affected by the dietary treatments.
Intestinal Microflora
As shown in Table 3 , chicks fed with ZnO-MMT had lower (P < 0.05) viable counts of Clostridium in small intestinal and cecal contents than those fed with basal diet, MMT, ZnO, or ZnSO 4 , whereas there was no (P > 0.05) difference in intestinal Escherichia coli among the treatments. Supplemental MMT, ZnO, or ZnSO 4 had no (P > 0.05) effect on intestinal microflora of chicks.
Ileal and Colonic Barrier Function
Ileal and colonic barrier function of chicks, as reflected by TER and paracellular flux of probe mannitol or inulin, is presented in Table 4 . As compared with the control, MMT, ZnO, or ZnSO 4 , supplementation with ZnO-MMT increased (P < 0.05) colonic TER values and reduced (P < 0.05) colonic mannitol permeability as well as ileal or colonic inulin permeability. The paracellular flux of mannitol in the ileum did not differ (P > 0.05) among treatments. Also in comparison with the control, dietary inclusion of MMT, ZnO, or ZnSO 4 did not affect ileal and colonic barrier function.
Morphological Measurement of the Small Intestinal Mucosa
As shown in Table 5 , villus height and the villus height to crypt depth ratio at the small intestinal mucosa were higher (P < 0.05) with ZnO-MMT supplementation compared with the control. Supplementation with ZnO also increased (P < 0.05) the villus height and the villus height to crypt depth ratio at the duodenum. Supplemental MMT or ZnSO 4 had no (P > 0.05) effect on intestinal morphology. Table 6 shows the digestive enzyme activities in the pancreas and the small intestinal contents. In pancreatic tissue, the trypsin activity increased (P < 0.05) in chicks fed ZnO-MMT or ZnSO 4 , whereas the activities of amylase, lipase, and chymotrypsin were unaffected. In small intestinal contents, and in comparison with the control, all digestive enzyme activities were greater (P < 0.05) in chicks fed ZnO-MMT, whereas feeding ZnSO 4 increased only trypsin activity (P < 0.05). Supplemental MMT or ZnO had no (P > 0.05) effect on digestive enzyme activities.
Digestive Enzymes
DISCUSSION
Effects of ZnO-MMT on Growth Performance
The NRC (1994) set zinc requirement for broilers during the starter period at a level of 40 mg/kg. When a corn-soybean meal diet was used, the Zn in the basal diet (usually more than 40 mg/kg) often met the requirement for chick growth, and there was no significant change in weight gain by Zn supplement (Wedekind et al., 1992) . A total dietary Zn concentration of 45~48 mg/kg (added as Zn sulfate) was sufficient for early chick growth (Mohanna and Nys, 1999; Huang et al., 2007) . However, Burrell et al. (2004) reported that optimum BW was achieved at 80 mg of supplemental zinc/kg with a maize-soybean meal basal diet containing 30 mg of zinc/kg. In the present study, there was no difference between the treatments when 60 mg of Zn/kg as AG ZnO or AG ZnSO 4 was added to the basal diets containing 42.4 mg of Zn/kg. In contrast to our results, Zn was about 40~80% bioavailable in feedgrade ZnO relative to feed-grade ZnSO 4 using weight gain as a response variable (Wedekind and Baker, 1990; Sandoval et al., 1997; Edwards and Baker, 1999) .
In recent years, MMT intercalated by drug molecules has attracted great interest. The MMT can accommodate drug molecules between its layers and the release of a drug from drug-intercalated MMT is potentially controllable (Aguzzi et al., 2007) . The MMT has been studied as a controlled-release carrier for various drug molecules and nutrient substance, such as vitamins B 6 (Joshi et al., 2009 ), amino acid (Kollár et al., 2003) , ibuprofen (Zheng et al., 2007) , donepezil (Park et al., 2008) , and chlorhexidine acetate (Meng et al., 2009 ). In the present study, ZnO-MMT was synthesized by a sol-gel intercalation between the colloidal suspension of exfoliated MMT nanosheets and the sol solution of zinc oxide reactants. Zinc oxide was intercalated into the interlayer space of MMT and also adsorbed on the surface of MMT (Khaorapapong et al., 2011) . It was reported that feeding 500 mg/kg of Zn as ZnO-MMT to early weaned pigs achieved the same effect of 2000 mg of Zn/kg as ZnO on alleviating the weaning-related intestinal disorders (Hu et al., 2012a,b) . The present study demonstrated that chicks fed with 60 mg of Zn/ kg as ZnO-MMT had higher ADG and ADFI than those fed with either MMT or 60 mg of Zn/kg as ZnO. The superior performance of ZnO-MMT may be at- tributed to ZnO-MMT interactions. The MMT, serving as a controlled-release carrier, might have modified the rate, time, or site of ZnO release (or a combination of these), as Zheng et al. (2007) reported that the release rate of MMT-ibuprofen in simulated intestinal fluid was noticeably higher than that in simulated gastric fluid.
Effects of ZnO-MMT on Intestinal Microflora
In pigs, high doses of ZnO have been associated with reduced bacterial translocation from the small intestine to the ileal mesenteric lymph node (Huang et al., 1999) , and with increased stability and homogeneity in coliform populations (Katouli et al., 1999) . However, Roselli et al. (2003) showed that ZnO protected cells from enterotoxigenic Escherichia coli-induced damage by inhibiting bacterial adhesion and internalization, not by a direct antibacterial effect. The present study showed that supplemental ZnO or ZnSO 4 had no effect on the number of Clostridium and Escherichia coli per gram of intestinal contents. This finding was in agreement with Jensen-Waern et al. (1998) who reported no effect on the number of E. coli and Enterococci per gram of feces when pigs were supplemented with 2,500 mg of Zn/kg as ZnO.
Our results showed that chicks fed with ZnO-MMT had lower viable counts of Clostridium in intestinal contents than those fed MMT or ZnO, whereas intestinal Escherichia coli was not affected. This finding is in agreement with the fact that gram-positive bacteria are more susceptible to ZnO than gram-negative bacteria (Sawai, 2003) . The superior antibacterial activity of ZnO-MMT may be attributed to ZnO-MMT interactions. A similar phenomenon was reported by Xia et al. (2004) , who found that copper-bearing MMT reduced the number of intestinal Clostridium and Escherichia coli, whereas equal amounts of MMT or CuSO 4 had no effect on intestinal microflora. They suggested that electrostatic attraction and the antibacterial effect of the Cu 2+ ion on bacteria are 2 ways of the antimicrobial action of copper-bearing MMT.
Effects of ZnO-MMT on Small Intestinal Morphology and Intestinal Barrier Function
Stressors that are present in the digesta can lead relatively to quick changes in the intestinal mucosa (Choct, 2009) . A shortening of the villus decreases the surface area for nutrient absorption. The crypt is the area where stem cells divide to permit the renewal of the villus, and a large crypt indicates fast tissue turnover and a high demand for new tissue (Hu et al., 2012a) . Changes in intestinal morphology, such as shorter villi and deeper crypts, can lead to poor nutrient absorption, increased secretion in the gut, diarrhea, reduced disease resistance, and impaired overall performance (Nabuurs et al., 1993; Hu et al., 2012a) . In the present study, supplementation with ZnO increased the villus height and the villus height to crypt depth ratio at the duodenum, but had no effect on morphology at the jejunum and ileum. However, villus height and the villus height to crypt depth ratio at the duodenum, jejunum, and ileum were all higher with ZnO-MMT supplementation compared with control. The reason for the above findings might be a sustained slow release of ZnO from ZnO-MMT during transport in the gastrointestinal tract.
Maintaining the integrity of the intestinal barrier is fundamental to the proper functioning of the epithelial cells and to preventing the entry of pathogenic bacteria that cause inflammation (Hu et al., 2012a) . Injured intestinal barrier increased the epithelial permeability. In the present study, ZnO-MMT increased colonic TER values, reduced the colonic permeability to both lowmolecular weight (mannitol) and high-molecular weight (inulin) markers. In contrast, ZnO-MMT did not affect mannitol permeability in the ileum. The ex vivo Ussing chamber to measure TER and paracellular flux of inu- a-c Means within a row with different letters differ significantly (P < 0.05). l Amylase activity unit was defined as the amount of amylase that will cause formation of reducing power equivalent to 1 mg of glucose in 1 h. Lipase activity unit was equal to the volume (mL) of 0.05 M NaOH required to neutralize the fatty acid liberated during 2 h incubation. One unit of trypsin or chymotrypsin activity was defined as the hydrolysis of 1 μmol of substrate/min.
2 MMT = montmorillonite. 3 ZnO-MMT = zinc oxide-montmorillonite hybrid, containing 10% Zn.
lin and mannitol is frequently used as a reliable and standard tool for screening and monitoring intestinal permeability (Awad et al., 2004; Smith et al., 2010; Peace et al., 2011) . It is known that inulin traverses the intestinal wall by paracellular pathways via the intercellular tight junctions, whereas mannitol passes predominantly by the transcellular pathways of epithelial villi (Smith et al., 2010; Peace et al., 2011) . The reduced colonic permeability to mannitol and inulin supported the idea of a tightening intestinal permeability for chicks fed dietary ZnO-MMT. In weaned pigs, dietary supplementation with 2000 mg of Zn/kg from ZnO reduced urinary lactulose:mannitol ratios, an in vivo index of intestinal permeability (Zhang and Guo, 2009) . Roselli et al. (2003) reported that ZnO protected intestinal cells from Escherichia coli K 88 infection by preventing the increase of tight junction permeability and modulating cytokine gene expression.
Effects of ZnO-MMT on the Digestive Enzyme Activities in the Pancreas and the Small Intestinal Contents
Zinc exerts a crucial role in the function of many enzymes. The present results that supplemental ZnO had no effect on digestive enzyme activities contrast with the previous studies. Ghiasi Ghalehkandi et al. (2011) found that supplemental 100 mg of Zn/kg as ZnO significantly increased leucine aminopeptidase enzyme activity in small intestine of broiler chicks. In weaned pigs, feeding 2,000 to 2,500 mg of Zn/kg as ZnO improved some digestive enzymes activities in pancreas tissue and small intestinal contents (Hedemann et al., 2006; Hu et al., 2012b) . The reason of the lack of effects of ZnO supplementation on digestive enzyme activities in this study may be because the concentration of ZnO (60 mg of Zn/kg) was not adequate. The present study showed that ZnO-MMT significantly suppressed intestinal Clostridium. Such changes in microbial ecosystem in the presence of ZnO-MMT might have contributed to its improvement in the digestive enzyme activities because Clostridium may damage the villus and microvillus of intestinal mucosa and inhibit the secretion of digestive enzymes (Mitsch et al., 2004) .
In conclusion, supplementation with 60 mg of Zn/kg as ZnO-MMT in broiler chickens improved growth performance, intestinal microflora, the digestive enzymes activities, intestinal morphology, and barrier function. The superior performance of ZnO-MMT over MMT or ZnO may be attributed to the controlled-release characteristic of MMT, which might have modified the release of ZnO further down in the intestinal tract.
